Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Invited commentary: Human papillomavirus infection and risk of cervical precancer--using the right methods to answer the right questions.

Franco EL, Tota J.

Am J Epidemiol. 2010 Jan 15;171(2):164-8. doi: 10.1093/aje/kwp392. Epub 2009 Dec 10.

2.

Impact of improved classification on the association of human papillomavirus with cervical precancer.

Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE.

Am J Epidemiol. 2010 Jan 15;171(2):155-63. doi: 10.1093/aje/kwp390. Epub 2009 Dec 10.

3.

Smoking enhances risk for new external genital warts in men.

Wiley DJ, Elashoff D, Masongsong EV, Harper DM, Gylys KH, Silverberg MJ, Cook RL, Johnson-Hill LM.

Int J Environ Res Public Health. 2009 Mar;6(3):1215-34. doi: 10.3390/ijerph6031215. Epub 2009 Mar 20.

4.

Comparison of the SPF10-LiPA system to the Hybrid Capture 2 Assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa Rica.

Safaeian M, Herrero R, Hildesheim A, Quint W, Freer E, Van Doorn LJ, Porras C, Silva S, González P, Bratti MC, Rodriguez AC, Castle P; Costa Rican Vaccine Trial Group.

J Clin Microbiol. 2007 May;45(5):1447-54. Epub 2007 Mar 7.

5.

The causal relation between human papillomavirus and cervical cancer.

Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV.

J Clin Pathol. 2002 Apr;55(4):244-65. Review.

6.

Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples.

Coutlée F, Gravitt P, Kornegay J, Hankins C, Richardson H, Lapointe N, Voyer H, Franco E.

J Clin Microbiol. 2002 Mar;40(3):902-7.

7.

Causality in medicine: the case of tumours and viruses.

Vonka V.

Philos Trans R Soc Lond B Biol Sci. 2000 Dec 29;355(1404):1831-41. Review.

8.
9.

Intermethod variation in detection of human papillomavirus DNA in cervical smears.

Smits HL, Bollen LJ, Tjong-A-Hung SP, Vonk J, Van Der Velden J, Ten Kate FJ, Kaan JA, Mol BW, Ter Schegget J.

J Clin Microbiol. 1995 Oct;33(10):2631-6.

10.

Pathogenesis of genital HPV infection.

Schneider A.

Genitourin Med. 1993 Jun;69(3):165-73. Review.

11.

Human papillomavirus, herpes simplex virus and other potential risk factors for cervical cancer in a high-risk area (Greenland) and a low-risk area (Denmark)--a second look.

Kjaer SK, de Villiers EM, Cağlayan H, Svare E, Haugaard BJ, Engholm G, Christensen RB, Møller KA, Poll P, Jensen H, et al.

Br J Cancer. 1993 Apr;67(4):830-7.

12.

Human papillomavirus and invasive cervical cancer in Brazil.

Eluf-Neto J, Booth M, Muñoz N, Bosch FX, Meijer CJ, Walboomers JM.

Br J Cancer. 1994 Jan;69(1):114-9.

13.

Genital human papillomavirus infection.

Lowy DR, Kirnbauer R, Schiller JT.

Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2436-40. Review.

14.

Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture.

Schiffman MH, Kiviat NB, Burk RD, Shah KV, Daniel RW, Lewis R, Kuypers J, Manos MM, Scott DR, Sherman ME, et al.

J Clin Microbiol. 1995 Mar;33(3):545-50.

15.

Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer.

Guerrero E, Daniel RW, Bosch FX, Castellsagué X, Muñoz N, Gili M, Viladiu P, Navarro C, Zubiri ML, Ascunce N, et al.

J Clin Microbiol. 1992 Nov;30(11):2951-9.

16.

Polymerase chain reaction detection of human papillomavirus: quantitation may improve clinical utility.

Morrison EA, Goldberg GL, Kadish AS, Burk RD.

J Clin Microbiol. 1992 Oct;30(10):2539-43.

Supplemental Content

Support Center